[HTML][HTML] Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19

M Bautista-Vargas, F Bonilla-Abadía… - Journal of thrombosis and …, 2020 - Springer
In December 2019, a new and highly contagious infectious disease emerged in Wuhan,
China. The etiologic agent was identified as a novel coronavirus, now known as Severe Acute …

Role of tissue factor in the pathogenesis of COVID-19 and the possible ways to inhibit it

…, M Bautista-Vargas, F Bonilla-Abadia - Clinical and Applied …, 2021 - journals.sagepub.com
COVID-19 (Coronavirus Disease 2019) is a highly contagious infection and associated with
high mortality rates, primarily in elderly; patients with heart failure; high blood pressure; …

Calcium, channels, intracellular signaling and autoimmunity

JH Izquierdo, F Bonilla-Abadía, CA Cañas… - … Clínica (English Edition), 2014 - Elsevier
Calcium (Ca 2+ ) is an important cation able to function as a second messenger in different
cells of the immune system, particularly in B and T lymphocytes, macrophages, and …

Direct oral anticoagulants in antiphospholipid syndrome: a real life case series

JF Betancur, F Bonilla-Abadía, AA Hormaza… - Lupus, 2016 - journals.sagepub.com
Aim The aim of this study was to describe a case series of patients with primary or secondary
antiphospholipid syndrome (APS) treated with direct oral anticoagulants (DOACs). Patients …

Efficacy and safety of anti–interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis

…, AF Echeverri, M Mejía, F Bonilla-Abadía… - JCR: Journal of …, 2014 - journals.lww.com
Purpose The aim of this study was to describe the efficacy and safety of anti–interleukin 6
receptor antibody (tocilizumab [TCZ]) in patients with severe or refractory Takayasu arteritis (TA…

Epigenetics changes associated to environmental triggers in autoimmunity

CA Canas, F Canas, F Bonilla-Abadía, FE Ospina… - …, 2016 - Taylor & Francis
Autoimmune diseases (AIDs) are chronic conditions initiated by the loss of immunological
tolerance to self-antigens and represent a heterogeneous group of disorders that affect …

Sequential rituximab and omalizumab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)

…, I Posso-Osorio, JC Bravo, F Bonilla-Abadía… - Clinical …, 2017 - Springer
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss
syndrome (CSS), is a small vessel vasculitis associated with eosinophilia and asthma. Clinical …

Calcio, canales, señalización intracelular y autoinmunidad

JH Izquierdo, F Bonilla-Abadía, CA Cañas… - Reumatología Clínica, 2014 - Elsevier
El calcio (Ca2+) es un catión con capacidad multifuncional como segundo mensajero en
diferentes grupos celulares del sistema inmunitario que incluyen los linfocitos T y B, los …

Pneumocystis jirovecii pneumonia in two patients with systemic lupus erythematosus after rituximab therapy

F Bonilla-Abadia, JF Betancurt, JC Pineda… - Clinical …, 2014 - Springer
New cases of Pneumocystis jirovecii pneumonia (PJP) have recently been reported in
patients with systemic lupus erythematosus (SLE) after rituximab therapy. Several factors may …

[HTML][HTML] Acute generalized exanthematous pustulosis due to tocilizumab in a rheumatoid arthritis patient

JH Izquierdo, F Bonilla-Abadía, CD Ochoa… - Case Reports in …, 2012 - hindawi.com
We report a female patient with rheumatoid arthritis which was refractory to methotrexate,
leflunomide, and anti-TNF therapy. She was treated with anti-IL-6 tocilizumab (TCZ), with an …